Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stéphane Goutagny

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
La Revue Du Praticien|February 24, 2007
[Meningiomas]Michel Kalamarides, Stéphane Goutagny
Journal of Neuro-Oncology|August 18, 2010
Meningiomas and neurofibromatosisStéphane Goutagny, Michel Kalamarides
British Journal of Neurosurgery|August 1, 2012
Increased growth rate of a WHO grade I ganglioglioma during pregnancySteven Knafo, Stéphane Goutagny, Johan Pallud
Journal of Neuro-Oncology|April 24, 2017
A 4-year phase II study of everolimus in NF2 patients with growing vestibular schwannomasStéphane Goutagny, Marco Giovannini, Michel Kalamarides
American Journal of Medical Genetics. Part A|January 17, 2013
Neurofibromatosis type 2 in the elderly population: clinical and molecular featuresStéphane Goutagny, Alpha B Bah, Béatrice Parfait, et al.
Brain Pathology (Zurich, Switzerland)|April 18, 2017
A 19-year-old male with a well-demarcated parieto-occipital massAurélie Beaufrère, Mathilde Fouet, Onorina Bruno, et al.
Cancer Chemotherapy and Pharmacology|May 6, 2016
Mechanism-based modeling of the clinical effects of bevacizumab and everolimus on vestibular schwannomas of patients with neurofibromatosis type 2Aziz Ouerdani, Stéphane Goutagny, Michel Kalamarides, et al.
Acta Neurochirurgica|February 9, 2020
Surface reconstruction from routine CT-scan shows large anatomical variations of falx cerebri and tentorium cerebelliHélène Staquet, Pierre-Marc Francois, Baptiste Sandoz, et al.
Journal of Neurosurgery|May 23, 2020
Validation of a scoring system to evaluate the risk of rapid growth of intracranial meningiomas in neurofibromatosis type 2 patientsSamiya Abi Jaoude, Matthieu Peyre, Vincent Degos, et al.
Brain Pathology (Zurich, Switzerland)|November 23, 2013
High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progressionStéphane Goutagny, Jean C Nault, Maxime Mallet, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
La Revue Du Praticien|February 24, 2007
[Meningiomas]Michel Kalamarides, Stéphane Goutagny
Journal of Neuro-Oncology|August 18, 2010
Meningiomas and neurofibromatosisStéphane Goutagny, Michel Kalamarides
British Journal of Neurosurgery|August 1, 2012
Increased growth rate of a WHO grade I ganglioglioma during pregnancySteven Knafo, Stéphane Goutagny, Johan Pallud
Journal of Neuro-Oncology|April 24, 2017
A 4-year phase II study of everolimus in NF2 patients with growing vestibular schwannomasStéphane Goutagny, Marco Giovannini, Michel Kalamarides
American Journal of Medical Genetics. Part A|January 17, 2013
Neurofibromatosis type 2 in the elderly population: clinical and molecular featuresStéphane Goutagny, Alpha B Bah, Béatrice Parfait, et al.
Brain Pathology (Zurich, Switzerland)|April 18, 2017
A 19-year-old male with a well-demarcated parieto-occipital massAurélie Beaufrère, Mathilde Fouet, Onorina Bruno, et al.
Cancer Chemotherapy and Pharmacology|May 6, 2016
Mechanism-based modeling of the clinical effects of bevacizumab and everolimus on vestibular schwannomas of patients with neurofibromatosis type 2Aziz Ouerdani, Stéphane Goutagny, Michel Kalamarides, et al.
Acta Neurochirurgica|February 9, 2020
Surface reconstruction from routine CT-scan shows large anatomical variations of falx cerebri and tentorium cerebelliHélène Staquet, Pierre-Marc Francois, Baptiste Sandoz, et al.
Journal of Neurosurgery|May 23, 2020
Validation of a scoring system to evaluate the risk of rapid growth of intracranial meningiomas in neurofibromatosis type 2 patientsSamiya Abi Jaoude, Matthieu Peyre, Vincent Degos, et al.
Brain Pathology (Zurich, Switzerland)|November 23, 2013
High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progressionStéphane Goutagny, Jean C Nault, Maxime Mallet, et al.
Pageof 4